Атомоксетин

Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) approved as a less stimulating treatment for ADHD in 2002 (U.S.). The precise mechanism by which it produces its therapeutic effects is unknown, but is thought to be related to its SNRI action.

Also known as: Strattera

Classification

Chemical: Medicine
Psychoactive: Stimulant
Tag: Pharmaceutical
Tag: Tentative

Effects

Increased Heart Rate
Stimulation
Talkativeness
Alertness Enhancement
Light Sensitivity

Routes of Administration

Oral

Dosage

Common: 18-40 mg
Light: 10-18 mg
Strong: 40-80 mg

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu